Abstract
Human pluripotent stem cell (hPSC)-based therapies offer promise but pose potential risks due to culture-acquired genetic variants, some of which have been linked with cancer. An international workshop addressed these concerns, highlighting the need for improved strategies to stratify variants and chart a path toward definitive guidelines in hPSC-based therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 508-512 |
| Number of pages | 5 |
| Journal | Cell Stem Cell |
| Volume | 32 |
| Issue number | 4 |
| DOIs |
|
| State | Published - 3 Apr 2025 |
Bibliographical note
Publisher Copyright:© 2025 Elsevier Inc.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'A call to action for deciphering genetic variants in human pluripotent stem cells for cell therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver